HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The mechanism of the formation and secretion of chylomicrons.

Abstract
The purpose of this review is to update the reader on our current understanding of the uptake and secretion of dietary lipid by the enterocyte to the periphery. This is a multi-stage process that first involves luminal digestion, followed by cellular uptake and processing, and subsequent extracellular transport of chylomicrons. We discuss the importance of acid and pancreatic lipase in lipid digestion. Micellar solubilization of fatty acids and 2-mono-acyl glycerol is critical to uptake by enhancing enterocyte exposure. There is controversy regarding the mechanism of fatty acid uptake by the enterocyte and whether this is mediated by a carrier-dependent process. The mechanism of fatty acid transport to the endoplasmic reticulum is discussed including the role of fatty acid binding proteins. Intracellularly, 2-monoacylglycerol and fatty acid are reconstituted to form triacylglycerol by the action of MGAT and DGAT. We focus on the mechanisms of intracellular chylomicron formation and secretion into lymph. Chylomicron and VLDL particles differ not only by an operational definition but likely represent two distinct pathways of intestinal lipoprotein formation. The physiologic role of apo B-48 in the intestine is presented as well as clinical disease of chylomicron metabolism, specifically abetalipoproteinemia and Anderson's disease.
AuthorsTammy Kindel, Dana M Lee, Patrick Tso
JournalAtherosclerosis. Supplements (Atheroscler Suppl) Vol. 11 Issue 1 Pg. 11-6 (Jun 2010) ISSN: 1878-5050 [Electronic] Netherlands
PMID20493784 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
CopyrightPublished by Elsevier Ireland Ltd.
Chemical References
  • Chylomicrons
  • Dietary Fats
  • Fatty Acids
  • Lipoproteins, VLDL
  • Monoglycerides
  • Lipase
Topics
  • Abetalipoproteinemia (metabolism)
  • Animals
  • Chylomicrons (metabolism)
  • Dietary Fats (metabolism)
  • Digestion
  • Enterocytes (metabolism)
  • Fatty Acids (metabolism)
  • Humans
  • Hypobetalipoproteinemias (metabolism)
  • Intestinal Mucosa (metabolism)
  • Lipase (metabolism)
  • Lipoproteins, VLDL (metabolism)
  • Malabsorption Syndromes (metabolism)
  • Monoglycerides (metabolism)
  • Pancreas (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: